PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1873.85%
Net income growth above 1.5x CRWD's 30.05%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-50.00%
Negative yoy D&A while CRWD is 6.21%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
52.79%
Well above CRWD's 61.99% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-4.82%
Both reduce yoy usage, with CRWD at -200.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.82%
Negative yoy usage while CRWD is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-51.20%
Negative yoy while CRWD is 14.15%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-5.31%
Both yoy CFO lines are negative, with CRWD at -13.35%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
53.42%
CapEx growth well above CRWD's 64.44%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
2.20%
Less growth in investment purchases vs. CRWD's 31.64%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-12.73%
Both yoy lines are negative, with CRWD at -36.63%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
-61.42%
We reduce yoy invests while CRWD stands at 52.10%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-25.52%
Both yoy lines negative, with CRWD at -200.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
52.95%
Buyback growth of 52.95% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.